Literature DB >> 7407511

Social environment and relapse in schizophrenia.

.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 7407511      PMCID: PMC1713641          DOI: 10.1136/bmj.281.6234.173

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  Experiences of discharged chronic schizophrenic patients in various types of living group.

Authors:  G W BROWN
Journal:  Milbank Mem Fund Q       Date:  1959-04

2.  Level of arousal and the subclassification of schizophrenia.

Authors:  P H VENABLES; J K WING
Journal:  Arch Gen Psychiatry       Date:  1962-08

3.  The measurement of expressed emotion in the families of psychiatric patients.

Authors:  C Vaughn; J Leff
Journal:  Br J Soc Clin Psychol       Date:  1976-06

4.  Trial of maintenance therapy in schizophrenia.

Authors:  J P Leff; J K Wing
Journal:  Br Med J       Date:  1971-09-11

5.  Influence of family life on the course of schizophrenic disorders: a replication.

Authors:  G W Brown; J L Birley; J K Wing
Journal:  Br J Psychiatry       Date:  1972-09       Impact factor: 9.319

6.  Crises and life changes preceding the onset or relapse of acute schizophrenia: clinical aspects.

Authors:  J L Birley; G W Brown
Journal:  Br J Psychiatry       Date:  1970-03       Impact factor: 9.319

7.  Prognosis of schizophrenia.

Authors:  D H Myers
Journal:  Br J Hosp Med       Date:  1978-11

8.  Bodily reactions to people and events in schizophrenics.

Authors:  N Tarrier; C Vaughn; M H Lader; J P Leff
Journal:  Arch Gen Psychiatry       Date:  1979-03

9.  The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients.

Authors:  C E Vaughn; J P Leff
Journal:  Br J Psychiatry       Date:  1976-08       Impact factor: 9.319

10.  The interaction of life events and relatives' expressed emotion in schizophrenia and depressive neurosis.

Authors:  J Leff; C Vaughn
Journal:  Br J Psychiatry       Date:  1980-02       Impact factor: 9.319

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.